Birgitta Sander - Concepedia

Author

Birgitta Sander

Also Known As

B Sander, B. SANDER, B. Sander, Birgitta M. Sander, Birgitta Sander, Brigitta Sander, D. Ewing, Sander, B., Sander, Birgitta

401

Publications

Citations

H-Index

102

Concepts

All Affiliations

Karolinska Institutet Karolinska University Hospital Uppsala University Stockholm University Lund University

About

Birgitta Sander is an author at Karolinska Institutet specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	44	3.9K
2	Cell Biology	17	23	1.3K
3	Health Sciences	8	8	2.2K
4	Allergy	3	3	198
5	Natural Sciences	1	1	29

Birgitta Sander

Publications

7.5K

Citations

H-Index

Page 1

	Year	Citations
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee Elı́as Campo, Elaine S. Jaffe, James R. Cook, Blood ImmunologyPathologyInternational Consensus ClassificationDermatologyLymphoid Neoplasms	2022	1.4K
Long-Term Complications, Immunologic Effects, and Role of Passage for Outcome in Mesenchymal Stromal Cell Therapy Lena von Bahr, Berit Sundberg, Lena Lönnies, Biology of Blood and Marrow Transplantation Cell TherapyImmunologyPathologyImmunotherapyRegenerative Medicine	2011	311
Immunohistochemical Prognostic Markers in Diffuse Large B-Cell Lymphoma: Validation of Tissue Microarray As a Prerequisite for Broad Clinical Applications—A Study From the Lunenburg Lymphoma Biomarker Consortium Daphne de Jong, Andreas Rosenwald, Mukesh Chhanabhai, Journal of Clinical Oncology	2007	304
Molecular Subsets of Mantle Cell Lymphoma Defined by the <i>IGHV</i> Mutational Status and SOX11 Expression Have Distinct Biologic and Clinical Features Alba Navarro, Guillem Clot, Cristina Royo, Cancer Research Sox11 ExpressionImmunologyPathologyClinical FeaturesTumor Biology	2012	249
Prognostic Significance of <i>MYC</i> Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium Andreas Rosenwald, Susanne Bens, Ranjana H. Advani, Journal of Clinical Oncology	2019	244
Lenalidomide inhibits the malignant clone and up-regulates the <i>SPARC</i> gene mapping to the commonly deleted region in 5q− syndrome patients Andrea Pellagatti, Martin Jädersten, Ann‐Mari Forsblom, Proceedings of the National Academy of Sciences	2007	230
Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium Gilles Salles, Daphne de Jong, Wanling Xie, Blood	2011	190
A Unifying Microenvironment Model in Follicular Lymphoma: Outcome Is Predicted by Programmed Death-1–Positive, Regulatory, Cytotoxic, and Helper T Cells and Macrophages Björn E. Wahlin, Mohit Aggarwal, Santiago Montes‐Moreno, Clinical Cancer Research	2010	188
Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases Anastasia Hadzidimitriou, Andreas Agathangelidis, Nikos Darzentas, Blood	2011	175
Retracted: Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium) Daphne de Jong, Wanling Xie, Andreas Rosenwald, Journal of Clinical Pathology	2008	169

Page 1